We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Gina Xiaojing Wang - Senior Principal Scientist (Chemistry), Discovery Chemistry

Gina Xiaojing Wang

Senior Principal Scientist (Chemistry), Discovery Chemistry

"Helping patients is my mission and innovation is the strategy. Innovating for life is especially meaningful and gratifying."
Years at Genentech
Publications at Genentech
Awards & Honors

I decided to join Genentech at 2006 as a scientist. What appealed me particularly to work at Genentech was the casual yet intense science-driven culture. Over the years, I led multiple disciplinary teams in driving projects towards deliveries into our pipeline of experimental therapies. It has been so much fun doing science together with super talented colleagues from all levels.

Today, I am a Principal Scientist and Project Team Lead, mentoring junior scientists and leading teams in discovering therapeutics of novel targets. What we are working on is often very challenging but we are fully motivated by patients who are waiting for breakthrough medicines.

Featured Publication

From Discovery to Bedside: Targeting the Ubiquitin System.

Cell Chem Biol. 2018 Nov 28. pii: S2451-9456(18)30382-9.

Wertz IE, Wang X.

Discovery of Potent and Selective Tricyclic Inhibitors of Bruton0s Tyrosine Kinase with Improved Druglike Properties.

ACS Med Chem Lett. 2017 May 3;8(6):608-613.

Wang X, Barbosa J, Blomgren P, Bremer MC, Chen J, Crawford JJ, Deng W, Dong L, Eigenbrot C, Gallion S, Hau J, Hu H, Johnson AR, Katewa A, Kropf JE, Lee SH, Liu L, Lubach JW, Macaluso J, Maciejewski P, Mitchell SA, Ortwine DF, DiPaolo J, Reif K, Scheerens H, Schmitt A, Wong H, Xiong JM, Xu J, Zhao Z, Zhou F, Currie KS, Young WB.